Official UK procurement notice
SARS-CoV-2 Antigen Rapid Qualitative Test Kits
Authority: Department of Health & Social Care (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: UK
Awarded value£722,051,003published contract · exc. VAT
Awarded 6 Oct 2020
Awarded to INNOVA MEDICAL GROUP INC.
Contract term 3 moends 31 Dec 2020 · starts 6 Oct 2020
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Diagnostic supplies
The lotProcurement structure
single lot · no lot value publishedLot #1Provision of lateral flow test kits and associated consumables
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 9 Feb 2021, 16:17 GMT
- Last source update
- 9 Feb 2021, 16:17 GMT
- FTS notice number
2021/S 000-002642- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0291b9Find a Tender
How it was run
Official notice- Submission deadline
- —
Timeline
6 Oct 2020 → 9 Feb 2021 · 2 dates- Contract starts6 Oct 2020, 00:00 BST
- Notice published9 Feb 2021, 16:17 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £722,051,0031 contract exc. VAT
Contracts signed 1latest 6 Oct 2020
| Awarded to | Value | Date | Status |
|---|---|---|---|
| INNOVA MEDICAL GROUP INC. | £722,051,003 † | — | Awarded |
Contracts
Contract 002642-2021-C13385-1 · INNOVA MEDICAL GROUP INC.
- Signed
- 6 Oct 2020
- Value
- £722,051,003
- Period
- 6 Oct 2020 – 31 Dec 2020
- Status
- active
- Change DHSC is relying on Regulation 72(1)(c) in order to modify the original contract:(a) the need for the modification has been brought about by circumstances which a diligent contracting authority cannot have foreseen:When the original contracts was entered into, DHSC purchased a sufficient volume of tests as was deemed strictly necessary to satisfy demand until an accelerated open procurement for testing kits had been completed.The demand for testing kits has exceeded expectations as a result of an unprecedented number of new cases which were not originally envisaged, and also as a result of additional requirements (e.g. testing university students, testing within the community, the mass testing of NHS personnel). As such, the demand for testing kits has been significantly higher than anticipated which could not have been foreseen when the original contract was entered into. The additional volumes of test kits procured pursuant to this modification is for a stopgap supply of test kits to cover the period between the current supply of kits being exhausted and those obtained pursuant to the contract awarded under the accelerated open procedure. (b) the modification does not alter the overall nature of the contract:The test kit components remain exactly the same as those covered by the original contract.(c) The value of the modification is less than 50% of the original contract value., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: DHSC awarded a contract on 6 October 2020 to Innova Medical Group Inc for the provision of lateral flow test kits to support the UK Covid-19 testing strategy (Contract Award Notice reference 2020/S 217-533961). DHSC is extending the contract relying on Regulation 72(1)(c) of the Public Contracts Regulations 2015 to procure additional volumes of tests until 31 December 2020. DHSC is conducting an accelerated procurement for future requirements (Contract Notice reference 2020/S 218-536544).
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- INNOVA MEDICAL GROUP INCAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.